| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $270.9M | +3.9% | +9.1% |
| R&D Expense | $39.9M | +6.6% | +15.2% |
| SG&A Expense | $36.1M | -2.4% | +21.6% |
| Operating Income | $36.3M | +20.8% | +3.4% |
| Pre-tax Income | $30.5M | +2.2% | +38.1% |
| Income Tax | $16.4M | +58.0% | +184.1% |
| Net Income | $14.1M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $479.4M | -3.6% | -10.2% |
| Accounts Receivable | $14.4M | +3.2% | +6.1% |
| Current Assets | $7.40B | +2.6% | +18.4% |
| Total Assets | $8.21B | +1.2% | +16.4% |
| Current Liabilities | $7.31B | +1.4% | +16.7% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $178.6M | — | — |
| Capital Expenditures | $12.3M | — | — |
| Investing Cash Flow | -$169.4M | — | — |
| Financing Cash Flow | $37.0M | — | — |
| Free Cash Flow | $166.3M | — | — |
| -27.5% |
| -66.0% |
| EPS (Basic) | $0.04 | -20.0% | -66.7% |
| EPS (Diluted) | $0.04 | -20.0% | -63.6% |
| $7.45B |
| +1.6% |
| +17.9% |
| Stockholders' Equity | $750.5M | -2.6% | +3.1% |